Diebold Nixdorf is rated Buy with potential upside if it successfully converts backlog and inventory into revenue and cash, especially in Q4. The retail segment saw a 24% year-on-year revenue increase, but profitability was challenged by lower margins and rising memory costs, while the banking segment improved margins to 36.8%. Achieving 2026 guidance depends heavily on a strong Q4 performance, focusing on inventory reduction and better service margins. The company's valuation is based on a 6.8x EBITDA multiple, targeting an equity value of about $2.8 billion or $84 per share, though execution and margin risks remain significant.
Diebold Nixdorf's outlook is detailed here with Pluang's Technology sector market snapshot as of Oct 07, 2026 21:31 WIB: out of 150 priced US tech stocks tradable on Pluang, 40 rose and 109 fell. Notable movers include Microchip Technology Inc. (MCHP) at USD 77.51 with a 1-day change of -4.61% and 100% sell order activity, Teradyne, Inc. (TER) at USD 410.48 down 4.61% with balanced buy/sell orders, and Rigetti Computing Inc. (RGTI) at USD 14.48 down 4.55% with 92% sell orders. The most notable figure is Microchip Technology's 100% sell order activity on Pluang.
BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...
Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...
Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...
Jito Labs has introduced JTX, a new self-custodial trading platform on the Solana blockchain. The platform supports spot trading of tokens, memecoins, tokenized equities, and ETFs, providing professional-grade execution tools. This launch aims to emp...
Evernorth's $1 billion XRP-only fund, initially set to debut on NASDAQ on October 8, 2026, has been postponed to October 12 due to an administrative delay. This delay does not affect the recent merger approval by Armada II shareholders or the fund's ...
